Skip to main content
Fig. 5 | BMC Genomic Data

Fig. 5

From: N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer

Fig. 5

Development of a Prognostic Signature. A and B Least absolute shrinkage and selection operator (LASSO) regression was performed, calculating the minimum criteria. C Kaplan–Meier survival analysis for the training and testing groups. D ROC (receiver operating characteristic) curves were used to evaluate the prediction efficiency of the prognostic signature

Back to article page